简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:Indian stocks declined as the still-rising coronavirus caseload made some investors question the sharp rebound from this years low.
Indian stocks declined as the still-rising coronavirus caseload made some investors question the sharp rebound from this years low.
The S&P BSE Sensex dropped 0.6% to 37,914.91 as of 10:26 a.m. in Mumbai. The gauge is up more than 45% from its March low even as the South Asian nation has become the third most-infected country in the world. Some of the technical indicators are signaling the bounce may have been overdone. The NSE Nifty 50 Index slid 0.4% to 11,148.70.
“The risk-reward is not great,” Surendra Goyal, an analyst at Citigroup Inc., wrote in a note, maintaining his March 2021 target for the Nifty at 10,500. The forecast level implies a drop of more than 6% from current levels. “It is difficult to make a fundamental argument around the flows/liquidity.”
The number of confirmed coronavirus cases in the worlds second-most populous nation stands at 1.39 million, according to data collected by Johns Hopkins University and Bloomberg News. A total of 32,063 people have died while 885,577 have recovered.
Ten of 15 Nifty 50 companies that have reported results so far have either beaten or met analyst estimates for profits while two results were not comparable, according to data compiled by Bloomberg. Kotak Mahindra Bank Ltd., Bharti Infratel Ltd. and Tech Mahindra Ltd. are set to announce earnings later in the day.
The rupee was little changed against the U.S. dollar, while the yield on the 10-year benchmark government bond fell 1 basis point to 5.81%.
The Numbers
Fifteen of 19 sector sub-indexes compiled by BSE Ltd. declined, led by a gauge of bank stocks
ICICI Bank Ltd. and Sun Pharmaceutical Industries Ltd. were the biggest losers on the Sensex, while Tata Consultancy Services Ltd. rose the most
Related Stories
Shake-Up Looms for Reserve Bank of Indias Rate-Setting Panel
ICICI Bank Reports Higher Profit, Helped by Insurance Unit Sales
Virus Ignites Investment Appeal of Indian Drugmakers Post Covid
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.